Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 8/20 | 0.44 |
| ▸ | EGLN3 | Q9H6Z9 | 8/20 | 0.43 |
| ▸ | EGLN2 | Q96KS0 | 3/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | SRC | P12931 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4359368 | 0.86 | EGLN3 (0.43) | EGLN1EGLN3EGLN2HIF1A | |
| SCHEMBL4363076 | 0.85 | EGLN1 (0.41) | EGLN1EGLN3EGLN2HIF1AKDM4E | |
| SCHEMBL4356985 | 0.84 | EGLN3 (0.43) | EGLN1EGLN3EGLN2HIF1AKDM4E | |
| SCHEMBL4362443 | 0.84 | EGLN3 (0.52) | EGLN1EGLN3EGLN2 | |
| SCHEMBL4364331 | 0.83 | HIF1A (0.43) | EGLN1EGLN3HIF1ATSHRHTT | |
| SCHEMBL3849956 | 0.83 | EGLN1 (0.44) | EGLN1EGLN3EGLN2HIF1A | |
| SCHEMBL3848478 | 0.83 | EGLN3 (0.49) | EGLN1EGLN3EGLN2HIF1A | |
| SCHEMBL4373002 | 0.83 | AKR1B1 (0.55) | EGLN1EGLN3EGLN2HIF1AMEN1 | |
| SCHEMBL4361363 | 0.83 | PTGDR2 (0.48) | EGLN1EGLN3HIF1AMEN1KMT2A | |
| SCHEMBL4359258 | 0.82 | EGLN3 (0.47) | EGLN1EGLN3EGLN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2124565-A2 | N-SUBSTITUTED GLYCINE DERIVATIVES: HYDROXYLASE INHIBITORS | Smithkline Beecham Corporation (US) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008089052-A2 | N-SUBSTITUTED GLYCINE DERIVATIVES: HYDROXYLASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-07-24 | — | — | WO | disclosed |